Cobalt and Chromium Ions Impair Macrophage Response to Staphylococcus aureus Infection
Source abstract
Abstract
Cobalt–chromium–molybdenum (CoCrMo) alloys are routinely used in arthroplasty. CoCrMo wear particles and ions derived from arthroplasty implants lead to macrophage-driven adverse local tissue reactions, which have been linked to an increased risk of periprosthetic joint infection after revision arthroplasty. While metal-induced cytotoxicity is well characterized in human macrophages, direct effects on their functionality have remained elusive. Synchrotron radiation X-ray microtomography and X-ray fluorescence mapping indicated that peri-implant tissues harvested during aseptic revision of different arthroplasty implants are exposed to Co and Cr in situ. Confocal laser scanning microscopy revealed that macrophage influx is predominant in patient tissue. While in vitro exposure to Cr 3+ had only minor effects on monocytes/macrophage phenotype, pathologic concentrations of Co 2+ significantly impaired both, monocyte/macrophage phenotype and functionality. High concentrations of Co 2+ led to a shift in macrophage subsets and loss of surface markers, including CD14 and CD16. Both Co 2+ and Cr 3+ impaired macrophage responses to Staphylococcus aureus infection, and particularly, Co 2+ -exposed macrophages showed decreased phagocytic activity. These findings demonstrate the immunosuppressive effects of locally elevated metal ions on the innate immune response and support further investigations, including studies exploring whether Co 2+ and Cr 3+ or CoCrMo alloys per se expose the patients to a higher risk of infections post-revision arthroplasty.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Orthopaedic implants and arthroplasty · Orthopedic Infections and Treatments · Bone Tissue Engineering Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Molecular Genetics and Infection Biology, University of Greifswald, Greifswald 17489,Germany
Center for Orthopaedics, Trauma Surgery and Rehabilitation Medicine, University Medicine Greifswald, Greifswald 17475, Germany
Swiss Light Source, Paul Scherrer Institute, Villigen-PSI 5232, Switzerland
Synchrotron SOLEIL, Saint-Aubin 91190, France
Xploraytion GmbH, Berlin 10625, Germany
ESRF-The European Synchrotron, Grenoble 38000, France
Funding
Agence Nationale de la Recherche · Deutsche Forschungsgemeinschaft
References (67)
Show source-provided references
1. 10.1016/j.jot.2022.10.01310.1016/j.jot.2022.10.013 ↗
2. 10.1302/2058-5241.6.21001310.1302/2058-5241.6.210013 ↗
3. 10.1016/j.biomaterials.2004.08.00410.1016/j.biomaterials.2004.08.004 ↗
4. 10.3389/fbioe.2019.0017610.3389/fbioe.2019.00176 ↗
5. 10.3109/17435390.2014.99143010.3109/17435390.2014.991430 ↗
6. 10.1016/j.actbio.2020.03.01710.1016/j.actbio.2020.03.017 ↗
7. 10.3389/fmats.2020.0027410.3389/fmats.2020.00274 ↗
8. 10.1016/j.arth.2020.02.00610.1016/j.arth.2020.02.006 ↗
9. 10.1007/s11999-013-2979-610.1007/s11999-013-2979-6 ↗
10. 10.1302/0301-620X.96B12.3347310.1302/0301-620X.96B12.33473 ↗
11. 10.1007/s11999.000000000000002910.1007/s11999.0000000000000029 ↗
12. 10.1302/0301-620X.91B8.2256210.1302/0301-620X.91B8.22562 ↗
13. 10.1007/s11999-013-3157-610.1007/s11999-013-3157-6 ↗
14. 10.1016/j.jcot.2019.09.02110.1016/j.jcot.2019.09.021 ↗
15. 10.1302/2046-3758.67.BJR-2017-0017.R210.1302/2046-3758.67.BJR-2017-0017.R2 ↗
16. 10.1007/s00132-023-04352-y10.1007/s00132-023-04352-y ↗
17. 10.1002/advs.20200041210.1002/advs.202000412 ↗
18. 10.1016/j.actbio.2019.05.07110.1016/j.actbio.2019.05.071 ↗
19. 10.1016/j.biomaterials.2016.04.02310.1016/j.biomaterials.2016.04.023 ↗
20. 10.1016/j.wear.2014.12.03010.1016/j.wear.2014.12.030 ↗
21. 10.1007/s10856-022-06675-210.1007/s10856-022-06675-2 ↗
22. 10.1016/j.jor.2020.08.01910.1016/j.jor.2020.08.019 ↗
23. 10.1055/a-1187-175110.1055/a-1187-1751 ↗
24. 10.3109/15563650.2014.94497710.3109/15563650.2014.944977 ↗
25. 10.1302/2058-5241.4.18009210.1302/2058-5241.4.180092 ↗
26. 10.1111/iwj.1264010.1111/iwj.12640 ↗
27. 10.2106/JBJS.19.0053710.2106/JBJS.19.00537 ↗
28. Renz, N.; Trampuz, A.; Perka, C.; Rakow, A. In Outcome and Failure Analysis of 132 Episodes of Hematogenous Periprosthetic Joint Infections─A Cohort Study, Open Forum Infectious Diseases; Oxford University Press US, 2022; p ofac094.10.1093/ofid/ofac094 ↗
29. 10.1080/17453674.2020.185153310.1080/17453674.2020.1851533 ↗
30. 10.1016/j.arth.2018.05.04210.1016/j.arth.2018.05.042 ↗
31. 10.1097/INF.000000000000163510.1097/INF.0000000000001635 ↗
32. 10.1128/CMR.00134-1410.1128/CMR.00134-14 ↗
33. 10.1016/j.arth.2023.02.06110.1016/j.arth.2023.02.061 ↗
34. 10.1056/NEJMra220347710.1056/NEJMra2203477 ↗
35. 10.1128/CMR.00111-1310.1128/CMR.00111-13 ↗
36. 10.3390/jcm805067310.3390/jcm8050673 ↗
37. 10.1016/j.cmi.2021.06.00610.1016/j.cmi.2021.06.006 ↗
38. 10.1016/j.cmi.2018.04.03510.1016/j.cmi.2018.04.035 ↗
39. 10.1002/jbm.a.3459910.1002/jbm.a.34599 ↗
40. 10.1146/annurev-pathmechdis-012418-01271810.1146/annurev-pathmechdis-012418-012718 ↗
41. 10.1111/imr.1222410.1111/imr.12224 ↗
42. 10.1093/toxsci/kfr12410.1093/toxsci/kfr124 ↗
43. 10.1016/j.actbio.2018.03.05410.1016/j.actbio.2018.03.054 ↗
44. 10.1088/1742-6596/2380/1/01212210.1088/1742-6596/2380/1/012122 ↗
45. 10.1088/1742-6596/849/1/01203710.1088/1742-6596/849/1/012037 ↗
46. 10.1016/j.sab.2006.12.00210.1016/j.sab.2006.12.002 ↗
47. Wick, M. R. In The hematoxylin and eosin stain in anatomic pathology─An often-neglected focus of quality assurance in the laboratory, Seminars in diagnostic pathology; Elsevier, 2019; pp 303–311.10.1053/j.semdp.2019.06.003 ↗
48. 10.1093/infdis/jiz16710.1093/infdis/jiz167 ↗
49. 10.1038/srep3136010.1038/srep31360 ↗
50. Krenn V. · 2017 · 110.1007/978-3-662-54204-0 ↗
51. 10.3390/ma1305115010.3390/ma13051150 ↗
52. 10.1016/j.nano.2017.08.00410.1016/j.nano.2017.08.004 ↗
53. 10.1016/j.nano.2016.11.00310.1016/j.nano.2016.11.003 ↗
54. 10.1186/s12907-018-0074-310.1186/s12907-018-0074-3 ↗
55. 10.1016/j.biomaterials.2015.07.03410.1016/j.biomaterials.2015.07.034 ↗
56. 10.1023/A:100887852723310.1023/A:1008878527233 ↗
57. 10.3390/lubricants303053910.3390/lubricants3030539 ↗
58. 10.1038/srep0572910.1038/srep05729 ↗
59. Yoshioka N. · Anticancer Res. · 2009 · 29 · 865
60. 10.1016/j.tiv.2014.11.00610.1016/j.tiv.2014.11.006 ↗
61. 10.1074/jbc.270.43.2576210.1074/jbc.270.43.25762 ↗
62. 10.1128/JCM.42.10.4846-4849.200410.1128/JCM.42.10.4846-4849.2004 ↗
63. Lu, Y.; Cai, W.J.; Ren, Z.; Han, P. The Role of Staphylococcal Biofilm on the Surface of Implants in Orthopedic Infection Microorganisms [Online], 2022.10.3390/microorganisms10101909 ↗
64. 10.1371/journal.ppat.100835410.1371/journal.ppat.1008354 ↗
65. 10.3109/17453674.2014.96629010.3109/17453674.2014.966290 ↗
66. 10.1172/JCI11130510.1172/JCI111305 ↗
67. 10.1093/infdis/146.4.48710.1093/infdis/146.4.487 ↗